EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TET2-loss enhances immediate and time-resolved interferon-γ signaling responses across myeloid differentiation

Matthew T Jenkins, Yunli E Chu, Alana M Franceski, Chad R Potts, Rebecca Dubin, Kirsten M Dickerson, Stanley C Lee, Rui Lu, Robert S Welner, P Brent Ferrell

Experimental Hematology · 2025

DOI: 10.1016/j.exphem.2025.104727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Hematology, 2025. Verfasst von Matthew T Jenkins und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Vanderbilt University, Nashville, TN; Department of Medicine, Division of Hematology/Oncology & Vanderbilt-Ingram Cancer …. Hauptthemen laut MEDLINE: Interferon-gamma, DNA-Binding Proteins, Signal Transduction, Proto-Oncogene Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Signaling responses to cytokines are disrupted in clonal hematopoiesis and myeloid malignancies. To better identify specific signaling response alterations in the presence or absence of TET2, we developed a 36-parameter cytometry by time-of-flight (CyTOF) panel of both surface marker and phosphoprotein antigens in murine bone marrow (BM). We show diverse, cell-type specific inflammatory cytokine responses in healthy hematopoietic cells. We next investigated changes associated with BM cells from Tet2KO mice. High-dimensional surface marker phenotyping revealed expansion of hematopoietic stem and progenitor cells (HSPCs), committed cKIT+Ly6C+ myeloid progenitors, and monocytes. Loss of TET2 function increased the magnitude of response to extracellular perturbations, including interferon (IFN)γ and H2O2. Response time courses revealed that IFNγ-mediated pSTAT1 remains elevated over time in Tet2KO. Further, IFNγ resulted in a more significant increase in major histocompatibility complex class II (MHCII) expression in Tet2KO immortalized progenitor cells than in Tet2WT. Inhibition of Janus kinase 1 and 2 (JAK1/2) with ruxolitinib significantly reduced STAT1 phosphorylation and MHCII expression in Tet2KO cells. Our results identify targetable disrupted signaling responses in Tet2KO cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon-gammaDNA-Binding ProteinsSignal TransductionProto-Oncogene ProteinsCell DifferentiationAnimalsDioxygenasesMiceMice, KnockoutSTAT1 Transcription FactorHematopoietic Stem CellsJanus Kinase 2

Substanzen

Interferon-gammaTet2 protein, mouseDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsSTAT1 Transcription FactorJanus Kinase 2Stat1 protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology, Vanderbilt University, Nashville, TN; Department of Medicine, Division of Hematology/Oncology & Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.
  • Department of Medicine, Division of Hematology/Oncology & Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashvi…
  • Division of Hematology/Oncology and O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL.
  • Department of Medicine, Division of Hematology/Oncology & Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.
  • Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Department of Medicine, Division of Hematology/Oncology & Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN; Nashville Veterans Affairs Hospital, Tennessee Valley Health Care, Departme…

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • BLRD VA
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Cancer Institute
  • National Heart Lung and Blood Institute

Zitieren

APA

Jenkins, M. T., Chu, Y. E., Franceski, A. M., Potts, C. R., Dubin, R., Dickerson, K. M., Lee, S. C., Lu, R., Welner, R. S., & Ferrell, P. B. (2025). TET2-loss enhances immediate and time-resolved interferon-γ signaling responses across myeloid differentiation. Experimental Hematology. https://doi.org/10.1016/j.exphem.2025.104727

Vancouver

Jenkins MT, Chu YE, Franceski AM, Potts CR, Dubin R, Dickerson KM, et al. TET2-loss enhances immediate and time-resolved interferon-γ signaling responses across myeloid differentiation. Experimental Hematology. 2025. doi:10.1016/j.exphem.2025.104727

BibTeX
@article{Jenkins2025,
  author = {Jenkins, Matthew T and Chu, Yunli E and Franceski, Alana M and Potts, Chad R and Dubin, Rebecca and Dickerson, Kirsten M and Lee, Stanley C and Lu, Rui and Welner, Robert S and Ferrell, P Brent},
  title = {TET2-loss enhances immediate and time-resolved interferon-γ signaling responses across myeloid differentiation},
  journal = {Experimental Hematology},
  year = {2025},
  doi = {10.1016/j.exphem.2025.104727}
}
Kostenlos starten →